Juniper Biosciences Builds Clinical and Commercial Leadership Teams with Appointments of Deepak Behera, M.D., as Chief Medical Officer, Javed Mahmood, Ph.D., as Senior Director of Clinical Development, and Robert Sgroi as Chief Commercial Officer
BEDMINSTER, N.J., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Juniper Biosciences ("Juniper" or "the Company"), a radiopharmaceutical drug development company, today announced the establishment of its clinical team with the appointments of Deepak Behera, M.D., as Chief Medical Officer and Javed Mahmood, D.D.S., Ph.D., as Senior Director of Clinical Development. Together, they will lead clinical development…
BEDMINSTER, N.J., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Juniper Biosciences ("Juniper" or "the Company"), a radiopharmaceutical drug development company, today announced the establishment of its clinical team with the appointments of Deepak Behera, M.D., as Chief Medical Officer and Javed Mahmood, D.D.S., Ph.D., as Senior Director of Clinical Development. Together, they will lead clinical development across Juniper's pipeline, including JBS-003 (18F-fluoromisonidazole, or FMISO), which is in a Phase 3 clinical trial and has received FDA Breakthrough Therapy Designation. The Company also announced the build-out of its commercial organization with the appointment of Robert Sgroi as Chief Commercial Officer, as it prepares for potential launches of its two late-stage diagnostic programs, JBS-002 and JBS-004.
In a release issued under the same headline earlier today by Dillard’s, Inc. (DDS: TXSE) please note that in the 1st paragraph, earnings will be released tomorrow after the close of the Texas Stock Exchange, not tomorrow before the open as previously stated. The corrected release follows:
The award-recognized women's wellness brand is making daily perimenopause support simpler, more convenient, and easier to try with its innovative oral dissolving strips. The award-recognized women's wellness brand is making daily perimenopause support simpler, more convenient, and easier to try with its innovative oral dissolving strips.
NEW YORK, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Investcorp Credit Management BDC, Inc. (NASDAQ: ICMB) (“ICMB”) and BCP Investment Corporation (NASDAQ: BCIC) (the “Company” or “BCIC”), a business development company managed by Sierra Crest Investment Management LLC (“Sierra Crest”), an affiliate of BC Partners Advisors L.P. (“BC Partners”), announced today that they have entered into…
AtlasClear Holdings signs its ninth correspondent agreement after FY2026 revenue rose 85% to $20.1 million, before material revenue from newly signed firms
Related Bing News Results Globe Newswire, World News and Updates | Ottawa Sun Tue, 10 Nov 2026 05:52:00 GMT LIDKÖPING, Sweden, Nov. 10, 2026 (GLOBE NEWSWIRE) — ASKO Professional made its first-ever appearance at Expodetergo International 2026 in Milan, marking an important step in bringing its Scandinavian ...
